Educational Resource
Retatrutide Weight Loss:
The Next Evolution in Metabolic Medicine
Retatrutide is an investigational triple-agonist therapy currently being studied for advanced weight loss. It is not FDA-approved and is not available for prescription use at Cellular Health & Aesthetics.
Retatrutide is not FDA-approved and is not available for prescription use. This page is for educational purposes only.
Educational content only. Lilly states retatrutide is an investigational molecule available only to participants in Lilly clinical trials. Source: Lilly
Retatrutide is currently in Phase 3 clinical trials and is not yet FDA-approved for general prescription use. Cellular Health & Aesthetics does not offer retatrutide at this time.
Retatrutide is not currently FDA-approved for general prescription use. Cellular Health & Aesthetics does not offer retatrutide at this time. This page exists to help patients understand the emerging science and avoid unsafe, unregulated sources.
What Is Retatrutide?
An Investigational Triple Hormone Receptor Agonist.
Retatrutide is a once-weekly investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. It is designed to address weight loss from multiple biological angles rather than relying on appetite suppression alone.
At Cellular Health & Aesthetics in Newnan, GA, we stay at the forefront of clinical science so patients can make informed decisions about current and future metabolic therapies.
How Retatrutide Works
Retatrutide Triple Agonist System.
Retatrutide is an investigational once-weekly peptide being studied for simultaneous activity across three hormone receptor pathways: GLP-1, GIP, and glucagon.
Therapy Evolution
The Evolution of Metabolic Therapy.
Semaglutide and tirzepatide represent current regulated medical weight loss options. Retatrutide remains a research-stage therapy and is not offered by Cellular Health & Aesthetics.
Currently available: Semaglutide and Tirzepatide medical weight loss programs.
Explore Current OptionsRetatrutide
Clinical Trial Results
Phase 3 TRIUMPH-1 Trial
Retatrutide is an investigational triple-agonist therapy. Results shown are from clinical trials. Individual results may vary.
Risks & Medical Considerations
Advanced Biology Requires Clinical Caution.
Lean Muscle Loss Risk
Rapid weight loss may include lean mass loss, making protein intake, resistance training, and biometric monitoring essential.
Heart Rate Increase
Glucagon receptor activation may increase resting heart rate and requires cardiovascular screening.
GI Side Effects
Nausea, constipation, and digestive discomfort can occur with incretin-based therapies.
Gallbladder Concerns
Rapid weight loss can increase gallstone risk and requires medical oversight.
Unregulated Product Risk
Any online source claiming to sell retatrutide outside a clinical trial should be treated with extreme caution.
Is Retatrutide Available Yet?
Not Yet. And That Matters.
Retatrutide is not FDA-approved for general use. Any website claiming to sell retatrutide outside of a clinical trial should be treated with extreme caution.
What You Can Do Now
Current Legal Programs for Metabolic Progress.
Candidate Profile
Who May Benefit From Advanced Medical Weight Loss?
- Stubborn weight despite diet and exercise
- Insulin resistance or metabolic syndrome
- Weight loss plateau
- Need for medically guided biometric tracking
- Interest in current FDA-approved therapies
FAQs
Retatrutide Questions, Answered Carefully.
Is retatrutide FDA-approved?
No. Retatrutide is currently investigational and has not received FDA approval for public prescription use.
Can Cellular Health prescribe retatrutide?
No. Cellular Health & Aesthetics does not offer retatrutide at this time.
How is it different from semaglutide?
Semaglutide targets GLP-1. Retatrutide is being studied as a triple agonist targeting GLP-1, GIP, and glucagon.
How is it different from tirzepatide?
Tirzepatide targets GLP-1 and GIP. Retatrutide adds glucagon receptor activity as an investigational third pathway.
What is closest right now?
Tirzepatide is currently one of the most advanced FDA-approved weight loss medication options available through regulated medical care.
Should I buy retatrutide online?
No. Any source claiming to sell retatrutide outside a clinical trial should be treated with extreme caution.
Start Safely
The Future Is Coming. Your Progress Can Start Now.
Retatrutide may represent the next major leap in medical weight loss, but you do not need to wait for future approval to begin improving your metabolic health.
Retatrutide is not available here. Current FDA-approved medical weight loss options may be appropriate depending on your health history, goals, and clinical evaluation.